Abstract: A substantially purified compound of the formula: a composition comprising a therapeutically effective amount of at least one compound of the formula, alone or in combination with at least one additional therapeutic agent, and methods of preventing or treating cancer and a condition treatable by the inhibition of vacuolar-type (H+)-ATPase
Type:
Application
Filed:
July 24, 2003
Publication date:
August 11, 2005
Applicant:
Gov of US, represented by Secretary, Dept of Healt